ALXN (7/24/11, +59.07%)
GNC (3/18/12, +2.18%)
LQDT (12/25/11, +29.59%)
ULTA (11/13/11, +29.30%)
MNST (10/16/11, +28.29%)
NUS (8/28/11, +56.72%)
MA (9/24/11, +25.81%)
DG (3/25/12, +0.00%)
DLTR (9/4/11, +33.04%)
TJX (3/25/12, +0.00%)
FAST (3/25/12, +0.00%)
Additions:
DG (3/25/12, +0.00%)
FAST (3/25/12, +0.00%)
TJX (3/25/12, +0.00%)
Subtractions:
None
Last week, the major U.S. indexes ended mixed. The Nasdaq moved up 0.4%, the S&P 500 gave up 0.5%, and the NYSE composite and the Dow each lost 1.1%. The IBD outlook remains at “confirmed uptrend”. On a net basis, the distribution levels remained unchanged. This was the worst week for stocks so far this year. If that’s as bad as it gets, this is going to be a pretty good year. Sooner or later, there will be a correction but, until then, it doesn’t pay to try and outguess the rising tape. Continue to ride the uptrend into the sunset until the market itself tells you to get out.
This week, one watch list stock is near a proper buy point. GNC, trading at $34.63, is still within 5% of a $33.80 buy point, off of a four weeks tight pattern.
/as usual, your mileage may vary, always do your own homework
Filed under: Blog Entry | Tagged: IBD, Investing, Investors Business Daily, Stocks, Watch List | 2 Comments »